Economic slowdown: Festival sales dip 40% in retail stores, footfall down 60%

Agencies
October 24, 2019

New  Delhi, Oct 24: As a consumption slowdown grips the economy, even festival season sales (September-October) have taken a massive hit this year, with sales down around 40 per cent compared to a year-ago period.

The Secretary General of the Confederation of All India Traders (CAIT) says the major reasons for decline in sales are cash crunch of consumers and the mass shift to the online markets on the back of "deep" discounts. Speaking to IANS, he said that the footfall in the brick and mortar shops including malls has taken a hit by around 60 per cent in comparison to last year

He was however, of the view that sales may witness a spike on 'Dhanteras', October 25.

"So far in comparison to last year, sales are down 40 per cent (during the festival season). Although traders have lost every hope, the jewellery sector feels, may be 'Dhanteras' would help jewellery along with utensils and kitchen equipment sales," Khandelwal said.

He also noted that the overall sentiment in the market is marked by "slowdown".

Further, as per Khandelwal, most of the retailers did not even fill their inventory ahead of the festival season, as done traditionally.

"People have not increased their inventory this year for the festival season. Generally, traders fill their inventory before two months, with a hope that the sales will rise, as prices then remain subdued," he said.

Referring to the lack of sales, he mentioned that around 70 per cent investment by retailers on inventory for Diwali has become "dead" investment.

Consumption slowdown in the country has been witnessed over the last few quarters. Although the government off late has announced a slew of measures to enhance liquidity and boost demand, so far the steps have not born fruit.

Khandelwal also puts a significant part of the blame of decline in offline retail sales on the heavy discounts on the online platforms.

Although the offline market is going through a lean phase despite festivals, major online platforms claim significant rise in sales during their festival sales whereby they offer discounts and offers.

CAIT has been protesting against the "deep discounts" for long and has recently asked the government to check whether the online platforms violate the norms for foreign direct investment (FDI).

Following which the government has sought replies from the major platforms with FDI regarding the allegations.

Despite the gloomy situation, there are instances of market players reporting a rise in their offline sales.

Lalit Agarwal, Chairman and Managing Director, V-Mart Retail said: "We have seen decent growth in sales during the festive season. When we talk about online retailers, the majority of their sales come from mobile phones and it didn't have an impact on our sales in small towns. We will continue to see growth in sales since marriages will start which means festive season will continue even after October."

By and large, the economy which is going through a prolonged phase of low demand and consumption across sectors would take some more time to revive and the retail sector might have to be patient for the return of the consumers and sales in good numbers.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

New Delhi, Apr 6: Prime Minister Narendra Modi on Monday said India's efforts to combat coronavirus have set an example and it is among countries which understood the pandemic's seriousness and took various timely decisions to combat the virus.

Addressing BJP workers to mark the 40th foundation day of the party, he also appreciated the maturity shown by people during the lockdown, describing it as  unprecedented.

"We got to see our collective strength on Sunday evening," he said referring to the countrywide exercise to switch off lights and illuminate diyas for nine minutes to show India's collective strength to fight the deadly virus.

He also urged BJP workers to follow a five-point agenda, including working to ensure that no poor goes hungry.

He asked them to follow the guidelines issued by party president J P Nadda.

Fight against coronavirus is no less than war, Modi said, asking BJP workers to donate and encourage others to contribute to the PM-CARES fund.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 22,2020

New Delhi, Jun 22: With an increase of 14,821 new cases and 445 deaths, India's COVID-19 count reached 4,25,282 on Monday.

According to the latest update by the Union Ministry of Health and Family Welfare (MoHFW), 13,699 deaths have been recorded due to the infection so far in the country.

The rise in confirmed cases today is lower than the highest spike of 15 thousand plus cases registered on Sunday.

The count includes 1,74,387 active cases, and 2,37,196 cured/discharged/migrated patients.

Maharashtra with 1,32,075 confirmed cases remains the worst-affected by the infection so far in the country. The state's count includes 60,161 active, 65,744 cured, discharged patients while 6,170 deaths have been reported due to the infection so far.

Meanwhile, the national capital today became the second-worst affected region in the country with the number of confirmed cases in Delhi reaching 59,746 as opposed to Tamil Nadu's 59,377 cases.

While 2,175 deaths have been reported in Delhi due to the infection so far, the toll in Tamil Nadu stands at 757.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.